UNSPSC 51172175: Meladrazine tartrate

This classification denotes an antispasmotic agent with the molecular formula C11H23N7.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7F3DYQ3H7H. European Medicines Agency schedules meladrazine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03125MIG. Most nations, for tariff and trade purposes, schedule meladrazine tartrate under HS 29336980 and SITC 51576. As of Q4 2014, MELADRAZINE TARTRATE remains US FDA's Preferred Term for this commodity.

SMILES: CCN(CC)C1[NH]/C(=N\N)/NC(N1)N(CC)CC.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51172175 Meladrazine tartrate is a Commodity code that does not reflect the scope of work actually being solicited under it in recent state and local procurement activity. The sole recent opportunity on record—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—concerns drug-testing laboratory operations, staffing, and confirmation methodologies (immunoassay screening, LC/MS/MS, GC/MS confirmation, oral fluid and hair testing), not the acquisition of meladrazine tartrate as a pharmaceutical product or chemical reagent. The RFP calls for annual testing of approximately 25,031 specimens across five-panel and six-panel screens with SAMHSA, TX DPS, or CAP lab certification required, structured around two collection sites in Plano and McKinney operating Monday through Friday plus five Saturdays annually.

Collin County, Texas, is the sole identified issuer of recent activity under this code. The RFP 2026-327, posted September 25, 2026 with a response deadline of July 23, 2026, carries an estimated contract value of $600,000 for an initial two-year term commencing September 1, 2026, with up to three optional one-year renewals through year five. Pricing is structured on a per-test basis across three service models (screening only, confirmation after screening, or screening with automatic confirmation of positives), with evaluation weighted toward vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), plus optional Phase 2 demonstration and interview scoring up to 30 additional points. This code shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope; the single opportunity surfaces a categorical mismatch between the UNSPSC taxonomy assignment and the services actually being procured.